Lamotrigin Stada

Lamotrigine, the active ingredient in Lamotrigin Stada, is an Anticonvulsant presented as an oral formulation for oral use. It is employed in the treatment of epilepsy and as a mood stabiliser in bipolar disorder.

GNH USA supplies Lamotrigin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant that acts on neuronal excitability in seizure disorders and mood regulation. - Epilepsy (partial seizures): helps control seizure frequency and severity. - Generalised tonic‑clonic seizures: reduces the occurrence of convulsive episodes. - Bipolar disorder (maintenance therapy): prevents depressive and manic episodes and stabilises mood.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash or skin irritation - Blurred vision - Fatigue

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous pemphigoid) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behaviour - Severe hypersensitivity reactions

When prescribing lamotrigine, clinicians should consider several safety measures. - Dose titration: increase gradually to minimise rash risk. - Skin reactions: monitor for rash and discontinue if severe. - Hepatic impairment: adjust dose if liver function is compromised. - Renal impairment: monitor renal function and adjust as needed. - Pregnancy: discuss potential risks with the prescriber, as safety data are limited. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma levels.

Major Interactions (Avoid): - Valproate: markedly increases lamotrigine concentrations, raising toxicity risk. - Carbamazepine: significantly reduces lamotrigine levels, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine concentrations, possibly leading to breakthrough seizures.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce lamotrigine levels; monitor seizure control. - Serotonergic agents: watch for signs of serotonin syndrome. - Other antiepileptics (e.g., phenytoin): may affect lamotrigine metabolism and require dose adjustments.